The tariff classification of Erlotinib Tablets and Lamotrigine Extended-Release Tablets in dosage form, from India
Reasoning
The tariff classification of Erlotinib Tablets and Lamotrigine Extended-Release Tablets in dosage form, from India
Cite this ruling
CBP Ruling N309743 (3004909215): The tariff classification of Erlotinib Tablets and Lamotrigine Extended-Release Tablets in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Niclosamide Tablets in dosage form
The tariff classification of Levalbuterol Hydrochloride vials in dosage form, from India
The tariff classification of Tadalafil Tablets in dosage form, from India
The tariff classification of Erythromycin Tablets and Esomeprazole Magnesium Delayed Release Oral Suspension in dosage form, from China and India, respectively
The tariff classification of Chlorpromazine Tablets in dosage form, from France